• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
936157

電子處方箋的全球市場 - 各零件 (解決方案，服務)、各部署方式 (內部部署方式，雲端方式)、各終端用戶 (醫院，開業醫生，製藥企業):機會分析與產業預測 (2019∼2026年)

E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2019-2026
出版日期: | 出版商: Allied Market Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

作為全球電子處方市場主要促進因素，各國政府的輔助策略和津貼支付，藥物濫用、假冒藥品的防止，醫療費削減的必要性等。尤其是，亞太地區的新興國家的普及動向，促進全球市場整體成長。

本報告提供全球電子處方箋的市場相關分析，產品概要和市場基本結構、最新趨勢，主要的推動及阻礙市場要素，今後的市場機會，市場規模的成果值、預測值 (今後8年份)，各零件、各部署方式、各終端用戶、各地區的詳細趨勢，主要企業的簡介等相關調查。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 左右電子處方箋市場的主要原因
  • 價值鏈分析
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 電子處方箋:產業發展藍圖
  • 各國政府的法規的影響

第4章 電子處方箋市場:各零件

  • 概要
  • 解決方案
    • 主要的市場趨勢，成長要素，機會
    • 市場規模與其預測:各地區
    • 市場分析:各國
  • 服務

第5章 電子處方箋市場:各部署方式

  • 概要
  • Web/雲端基礎
  • 內部部署

第6章 電子處方箋市場:各終端用戶

  • 概要
  • 醫院
  • 開業醫生
  • 製藥企業

第7章 電子處方箋市場:各地區

  • 概要
    • 市場規模與預測:各地區
  • 北美
    • 主要的市場趨勢，成長要素，機會
    • 市場規模與其預測:各零件
    • 市場規模與其預測:各部署方式
    • 市場規模與其預測:各終端用戶
    • 市場分析:各國
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第8章 競爭環境

  • 各企業的市場定位 (2018年)
  • 最優秀策略
  • 市場主要趨勢
    • 新產品的銷售
    • 夥伴關係 (事業聯盟)
    • 事業擴張
    • 企業收購
    • 合作 (事業合作)
  • 專利分析
    • 各地區(2016∼2019年)
    • 各申請者

第9章 企業簡介

  • Allscripts Healthcare, LLC
    • 基本資料
    • 經營團隊
    • 企業概要
    • 事業區分
    • 產品系列
    • 研究開發 (R&D) 費
    • 業績
    • 主要策略的發展情形，市場主要趨勢
  • Athenahealth, Inc.
  • Cerner Corporation
  • Change Healthcare
  • DrFirst.com, Inc.
  • eClinicalWorks
  • Epic Systems Corporation
  • Medical Information Technology, Inc.
  • Practice Fusion, Inc.
  • Surescripts
目錄
Product Code: LI_182004

Electronic prescribing or e-prescribing is a digital application that securely provides bidirectional electronic information exchange between payers/PBMs, pharmacies, prescribing providers, directly or through an intermediary network. E-prescribing includes routing prescriptions that ensures prescribed drug against the patient's health formulary of covered drugs, obtains prior authorization, gains any known patient drug allergies, identifiesany drug-drug interactions, provides access to patients' medication history from external sources, and sends or receives acknowledgement of prescriptions filled. The major capability of e-prescribing is to support important process in care delivery, such as medication management, medication reconciliation, and prior authorization, this in turn is driving the e-prescribing market growth.

Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.

The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the current & future trends of the market to elucidate the imminent investment pockets.
  • Information about key drivers, restraints, and opportunities and their impact analysis on the global e-prescribing market size is provided.
  • Porter's five forces analysis illustrates the potency of the buyers and suppliers operating in the global e-prescribing industry.
  • The quantitative analysis of the market from 2018 to 2026 is provided to determine the global e-prescribing market potential.

KEY MARKET SEGMENTS

By Component

  • Solutions
  • Services

By Deployment

  • On-premise
  • Cloud

By End User

  • Hospitals
  • Office-based Physicians
  • Pharmaceuticals

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

KEY MARKET PLAYERS

  • Allscripts Healthcare, LLC
  • Athenahealth, Inc.
  • Cerner Corporation
  • Change Healthcare
  • DrFirst.com, Inc.
  • eClinicalWorks
  • Epic Systems Corporation
  • Medical Information Technology, Inc.
  • Practice Fusion, Inc.
  • Surescripts

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. KEY MARKET PLAYERS
  • 1.5. RESEARCH METHODOLOGY
    • 1.5.1. Secondary research
    • 1.5.2. Primary research
    • 1.5.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS
    • 2.1.1. Top impacting factors
    • 2.1.2. Top investment pockets
  • 2.2. CXO PERSPECTIVE

CHAPTER 3: MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
  • 3.3. VALUE CHAIN ANALYSIS
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
      • 3.4.1.1. Government initiatives and incentive programs
      • 3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
      • 3.4.1.3. Need to curtail escalating healthcare costs
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of systems
      • 3.4.2.2. Security & workflow issues
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth in the developing countries across Asia-Pacific
  • 3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
  • 3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET

CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT

  • 4.1. OVERVIEW
  • 4.2. SOLUTIONS
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market analysis, by country
  • 4.3. SERVICES
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market analysis, by country

CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT

  • 5.1. OVERVIEW
  • 5.2. WEB & CLOUD-BASED
    • 5.2.1. Key market trends, growth factors, and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market analysis, by country
  • 5.3. ON-PREMISE
    • 5.3.1. Key market trends, growth factors, and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market analysis, by country

CHAPTER 6: E-PRESCRIBING MARKET, BY END USER

  • 6.1. OVERVIEW
  • 6.2. HOSPITALS
    • 6.2.1. Key market trends, growth factors, and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market analysis, by country
  • 6.3. OFFICE-BASED PHYSICIANS
    • 6.3.1. Key market trends, growth factors, and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market analysis, by country
  • 6.4. PHARMACEUTICALS
    • 6.4.1. Key market trends, growth factors, and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market analysis, by country

CHAPTER 7: E-PRESCRIBING MARKET, BY REGION

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast, by region
  • 7.2. NORTH AMERICA
    • 7.2.1. Key market trends, growth factors, and opportunities
    • 7.2.2. Market size and forecast, by component
    • 7.2.3. Market size and forecast, by deployment
    • 7.2.4. Market size and forecast, by end user
    • 7.2.5. Market analysis, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by component
      • 7.2.5.1.2. Market size and forecast, by deployment
      • 7.2.5.1.3. Market size and forecast, by end user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by component
      • 7.2.5.2.2. Market size and forecast, by deployment
      • 7.2.5.2.3. Market size and forecast, by end user
  • 7.3. EUROPE
    • 7.3.1. Key market trends, growth factors, and opportunities
    • 7.3.2. Market size and forecast, by component
    • 7.3.3. Market size and forecast, by deployment
    • 7.3.4. Market size and forecast, by end user
    • 7.3.5. Market analysis, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by component
      • 7.3.5.1.2. Market size and forecast, by deployment
      • 7.3.5.1.3. Market size and forecast, by end user
      • 7.3.5.2. UK
      • 7.3.5.2.1. Market size and forecast, by component
      • 7.3.5.2.2. Market size and forecast, by deployment
      • 7.3.5.2.3. Market size and forecast, by end user
      • 7.3.5.3. France
      • 7.3.5.3.1. Market size and forecast, by component
      • 7.3.5.3.2. Market size and forecast, by deployment
      • 7.3.5.3.3. Market size and forecast, by end user
      • 7.3.5.4. Rest of Europe
      • 7.3.5.4.1. Market size and forecast, by component
      • 7.3.5.4.2. Market size and forecast, by deployment
      • 7.3.5.4.3. Market size and forecast, by end user
  • 7.4. ASIA-PACIFIC
    • 7.4.1. Key market trends, growth factors, and opportunities
    • 7.4.2. Market size and forecast, by component
    • 7.4.3. Market size and forecast, by deployment
    • 7.4.4. Market size and forecast, by end user
    • 7.4.5. Market analysis, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by component
      • 7.4.5.1.2. Market size and forecast, by deployment
      • 7.4.5.1.3. Market size and forecast, by end user
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by component
      • 7.4.5.2.2. Market size and forecast, by deployment
      • 7.4.5.2.3. Market size and forecast, by end user
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by component
      • 7.4.5.3.2. Market size and forecast, by deployment
      • 7.4.5.3.3. Market size and forecast, by end user
      • 7.4.5.4. Rest of Asia-Pacific
      • 7.4.5.4.1. Market size and forecast, by component
      • 7.4.5.4.2. Market size and forecast, by deployment
      • 7.4.5.4.3. Market size and forecast, by end user
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors, and opportunities
    • 7.5.2. Market size and forecast, by component
    • 7.5.3. Market size and forecast, by deployment
    • 7.5.4. Market size and forecast, by end user
    • 7.5.5. Market analysis, by country
      • 7.5.5.1. Latin America
      • 7.5.5.1.1. Market size and forecast, by component
      • 7.5.5.1.2. Market size and forecast, by deployment
      • 7.5.5.1.3. Market size and forecast, by end user
      • 7.5.5.2. Middle East
      • 7.5.5.2.1. Market size and forecast, by component
      • 7.5.5.2.2. Market size and forecast, by deployment
      • 7.5.5.2.3. Market size and forecast, by end user
      • 7.5.5.3. Africa
      • 7.5.5.3.1. Market size and forecast, by component
      • 7.5.5.3.2. Market size and forecast, by deployment
      • 7.5.5.3.3. Market size and forecast, by end user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
  • 8.2. TOP WINNING STRATEGIES
  • 8.3. KEY DEVELOPMENTS
    • 8.3.1. Product launches
    • 8.3.2. Partnership
    • 8.3.3. Business expansion
    • 8.3.4. Acquisition
    • 8.3.5. Collaboration
  • 8.4. PATENT ANALYSIS
    • 8.4.1. By region (2016-2019)
    • 8.4.2. By applicant

CHAPTER 9: COMPANY PROFILE

  • 9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. R&D Expenditure
    • 9.1.7. Business performance
    • 9.1.8. Key strategic moves and developments
  • 9.2. ATHENAHEALTH, INC.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Product portfolio
    • 9.2.5. Key strategic moves and developments
  • 9.3. CERNER CORPORATION
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Product portfolio
    • 9.3.5. Business performance
    • 9.3.6. Key strategic moves and developments
  • 9.4. CHANGE HEALTHCARE
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Product portfolio
    • 9.4.5. Key strategic moves and developments
  • 9.5. DRFIRST
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Product portfolio
    • 9.5.5. Key strategic moves and developments
  • 9.6. ECLINICALWORKS
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Product portfolio
    • 9.6.5. Key strategic moves and developments
  • 9.7. EPIC SYSTEMS CORPORATION
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Product portfolio
    • 9.7.5. Key strategic moves and developments
  • 9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Product portfolio
    • 9.8.5. Key strategic moves and developments
  • 9.9. PRACTICE FUSION, INC.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Product portfolio
    • 9.9.5. Key strategic moves and developments
  • 9.10. SURESCRIPTS
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Product portfolio
    • 9.10.5. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018-2026 ($MILLION)
  • TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018-2026 ($MILLION)
  • TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 2018-2026 ($MILLION)
  • TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018-2026 ($MILLION)
  • TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018-2026 ($MILLION)
  • TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018-2026 ($MILLION)
  • TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
  • TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
  • TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
  • TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
  • TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
  • TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
  • TABLE 68. PARTNERSHIP (2016-2019)
  • TABLE 69. KEY EXPANSION (2016-2019)
  • TABLE 70. KEY ACQUISITION (2016-2019)
  • TABLE 71. COLLABORATION (2016-2019)
  • TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
  • TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
  • TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
  • TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
  • TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
  • TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
  • TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
  • TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
  • TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 85. DRFIRST: KEY EXECUTIVES
  • TABLE 86. DRFIRST: COMPANY SNAPSHOT
  • TABLE 87. DRFIRST: PRODUCT PORTFOLIO
  • TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
  • TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
  • TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
  • TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
  • TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
  • TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
  • TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
  • TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
  • TABLE 100. SURESCRIPTS: KEY EXECUTIVES
  • TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
  • TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. KEY MARKET SEGMENTS
  • FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018-2026
  • FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018-2026
  • FIGURE 04. TOP IMPACTING FACTORS
  • FIGURE 05. TOP INVESTMENT POCKETS
  • FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
  • FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
  • FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
  • FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
  • FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
  • FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
  • FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
  • FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
  • FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018-2025
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018-2026 ($MILLION)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018-2026 ($MILLION)
  • FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
  • FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
  • FIGURE 43. PATENT ANALYSIS, BY REGION
  • FIGURE 44. PATENT ANALYSIS, BY APPLICANT
  • FIGURE 45. R&D EXPENDITURE, 2016-2018 ($MILLION)
  • FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 49. CERNER CORPORATION: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)